XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Note 9 - Net Loss Per Share of Common Stock
3 Months Ended
Mar. 31, 2022
Notes to Financial Statements  
Earnings Per Share [Text Block]

9. Net loss per share of Common Stock

 

The following table summarizes the computation of basic and diluted net loss per share of the Company (in thousands, except per share data):

 

  

Three Months Ended

 
  

March 31,

 
  

2022

  

2021

 

Net loss

 $(13,057) $(8,004)

Basic and diluted net loss per share

 $(0.62) $(0.44)

Weighted-average shares used to compute basic and diluted net loss per share

  21,130   18,067 

 

Basic net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Weighted-average number of common shares outstanding for the period includes the weighted average effect of the Company’s pre-funded warrants issued on March 31, 2022, the exercise of which is not subject to contingencies and requires little or no consideration.  Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and dilutive common stock equivalents outstanding for the period, determined using the treasury-stock method and the as-if converted method, for convertible securities, if inclusion of these is dilutive. Because the Company has reported a net loss for each of the three months ended March 31, 2022 and 2021, the Company did not have dilutive common stock equivalents and therefore diluted net loss per common share is the same as basic net loss per common share for those periods.

 

The following potentially dilutive securities outstanding at the end of the three months ended March 31, 2022 and 2021 have been excluded from the computation of diluted shares outstanding:

 

  

Three Months Ended

 
  

March 31,

 
  

2022

  

2021

 

Options to purchase common stock

  3,677,075   2,540,737 

Pre-funded warrants to purchase common stock

  4,545,455    

Common stock warrants

  4,850,241